Dr. Mirella Díaz-Santos was featured in the Women’s Alzheimer’s Movement newsletter this week for a Q&A on engaging with the Latinx community.
Dr. Daniel Geschwind was quoted in a HealthDay article on a study that found that the "feel good" hormone won't help ease kids' autism.
Dr. Aharoni received a highly competitive and honorific NIH Director's New Innovator Award (termed a “DP2”), entitled “Developing long-term neuro-behavioral recording and real-time processing platforms for naturally behaving animals”.
Dr. Stern was recently chosen by the American Epilepsy Society Board of Directors to become the Treatments Committee Chair in 2022.
Dr. Rhonda Voskuhl discusses the remaining challenges of "B-Cell Depletion and COVID-19 Severity in Multiple Sclerosis."
Dr. Steven Cramer was awarded an U01 NIH grant, entitled Validation of Early Progrnostic Data for Recovery Outcomes after Stroke for Future, Higher Yield Trails (VERIFY).
In this original article, Dr. S. Thomas Carmichael and others present a synopsis of topics and discussion covered in the 2021 Annual Workshop of the Albert Research Institute for White Matter and Cognition.
The findings from this recent study by Dr. Allan MacKenzie-Graham demonstrate that neuronal PAC1 receptors play a homeostatic role in protecting RGNs and directly protects brain cells and their axons against neuroinflammatory challenge.
Several new therapeutic strategies have emerged to address unmet clinical needs in high-grade gliomas. This review by Dr. Timothy Cloughesy highlights these strategies & outlines how imaging technology can be used for therapeutic response evaluation.
The clinical characteristics of functional seizures may vary based on age. Drs. Jerome Engel and John Stern evaluated how factors continuously varied based on age-of-presentation across the adult lifespan.